OASIS™ takes project tracking to a whole new level. Specifically designed for pharmaceutical, medical, and consumer healthcare applications, OASIS™ is the most comprehensive marketing dashboard system ever developed within the pharmaceutical/healthcare industry.

Password:


OASIS™ Login

Terms & Conditions

PLEASE READ THESE TERMS AND CONDITIONS OF USE CAREFULLY BEFORE USING THIS SITE.

By using this website you accept these terms and conditions of use. If you do not agree to these terms and conditions of use, please do not use this website. PharmaCommunications™ reserves the right, at its discretion, to change, modify, add or remove portions of these terms and conditions at any time. You should therefore review these terms and conditions each time you access this website. Changes or updates to the contents of this website may also occur without notice. Except where stated otherwise, the term PharmaCommunications™ used on this website shall be deemed to include PharmaCommunications Group Inc. and its licensors, affiliates, subsidiaries, successors and assigns.

No Warranty or Representation
While PharmaCommunications™ uses reasonable efforts to include accurate and up-to-date information on this website, your use and browsing of this website is at your own risk. Nothing in this website, including product or service information, shall add to or change any contract for products or services you may have with PharmaCommunications™.

This website and the information or materials herein are provided on an “as is” basis. PharmaCommunications™ makes no representation or warranty, either express or implied, of any kind with respect to this website or its contents including, but not limited to, merchantability, fitness for a particular purpose, and non-infringement.

None of PharmaCommunications™ or any of its respective directors, employees, agents, or other representatives will be liable for damages, claims, expenses or other costs (including without limitation legal fees) arising out of or in connection with the use of, or inability to use, this website or any information contained on it, or any hyperlinked website. This is a comprehensive limitation of liability that applies to all damages of any kind, including (without limitation) compensatory, direct, indirect, exemplary, punitive and consequential damages, loss of programs or data, income or profit, loss or damage to property and claims of third parties. You agree that use of this website is at your sole risk and that your exclusive and sole remedy is to stop using this website.


Restrictions on Use of Materials

Trademarks
Medication Information Center/Centrale des Médicaments, and Health Loyalty/Fidélité Santé are divisions of PharmaCommunications Group Inc. The OASIS™ Oversight and Analytics System (OasisAnalytics.com) and PharmaSalesSupport.com™ and their related software are owned by PharmaCommunications Holdings Inc. and used under license by PharmaCommunications Group Inc. and its affiliates.

PharmaCommunications™, pharmaGram™, pharmaGram Fax™, pharmaGram E-Mail™, pharmaFax™, Territory Support Services™, Priority Communications from Canada’s Pharmaceutical Industry™, Communications prioritaires de l’industrie pharmaceutique canadienne™, It's not just the medium, it's part of the message™, C’est non seulement le médium, c’est un élément du message™, MedBase™, Medical Dialogue™, Dialogue Médical™, Medication Information Center™, Centrale des Médicaments™, Health Loyalty™, Fidélité Santé™, PharmaSalesSupport.com™, SupportVentesPharma.com™, and OASIS™ are trademarks of PharmaCommunications Holdings Inc., with PharmaCommunications Group Inc. and its affiliates as licensees. All other trademarks are the property of their respective owners.

Copyright
© 2013 PharmaCommunications Group Inc. All rights reserved.

All material contained on this website including the content, site design, text, graphics, and the selection and arrangement thereof are the copyright of PharmaCommunications Group Inc. No material from this website or any of PharmaCommunications™ trademarks may be copied, reproduced, modified, linked to, or used or distributed in any way, without the express written authorization of PharmaCommunications Group Inc. Failure to do so is a violation of this agreement and an infringement of PharmaCommunications Group Inc. copyright and other proprietary rights, and is expressly prohibited.


Linkage
As a service to users of this website, PharmaCommunications™ includes links to other web sites that PharmaCommunications™ has no control over, and makes no endorsements or representations of any kind regarding the products, services, business practices, content or appropriateness of content on such web sites, and the user hereby irrevocably waives any claim against PharmaCommunications™ with respect to such web sites.

Indemnity
You agree to indemnify, defend and hold harmless PharmaCommunications Group Inc., its affiliates, officers, directors, employees, agents, licensors, and suppliers from and against all losses, expenses, damages and costs, including reasonable attorneys’ fees, resulting from your violation of these terms and conditions or any activity (including negligent or wrongful conduct) related to your use of this website.

Governing Law and Jurisdiction
By visiting this website, you agree that all matters related to the access to, or use of, this website shall be governed by the laws of the Province of Ontario and the federal laws of Canada applicable therein. You agree to be bound by the laws of these jurisdictions and submit to the exclusive personal jurisdiction and venue of the courts of Ontario, Canada.

General
The terms and conditions on this website constitute the entire agreement between you and PharmaCommunications™ governing your use of this website. The failure or delay of PharmaCommunications™ in exercising any right or remedy under the terms and conditions or elsewhere shall not constitute a waiver of such right or remedy. The section titles in these terms and conditions are for convenience only and have no legal or contractual effect.

Back to Top © 2013, PharmaCommunications Group Inc.